BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 27591183)

  • 1. Reasons for Lack of Diagnostic Colonoscopy After Positive Result on Fecal Immunochemical Test in a Safety-Net Health System.
    Martin J; Halm EA; Tiro JA; Merchant Z; Balasubramanian BA; McCallister K; Sanders JM; Ahn C; Bishop WP; Singal AG
    Am J Med; 2017 Jan; 130(1):93.e1-93.e7. PubMed ID: 27591183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time to Follow-up After Colorectal Cancer Screening by Health Insurance Type.
    Breen N; Skinner CS; Zheng Y; Inrig S; Corley DA; Beaber EF; Garcia M; Chubak J; Doubeni C; Quinn VP; Haas JS; Li CI; Wernli KJ; Klabunde CN;
    Am J Prev Med; 2019 May; 56(5):e143-e152. PubMed ID: 31003603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system.
    Singal AG; Gupta S; Tiro JA; Skinner CS; McCallister K; Sanders JM; Bishop WP; Agrawal D; Mayorga CA; Ahn C; Loewen AC; Santini NO; Halm EA
    Cancer; 2016 Feb; 122(3):456-63. PubMed ID: 26535565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-Reported Barriers to Completing a Diagnostic Colonoscopy Following Abnormal Fecal Immunochemical Test Among Uninsured Patients.
    Jetelina KK; Yudkin JS; Miller S; Berry E; Lieberman A; Gupta S; Balasubramanian BA
    J Gen Intern Med; 2019 Sep; 34(9):1730-1736. PubMed ID: 31228053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
    Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
    JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceptions on Barriers and Facilitators to Colonoscopy Completion After Abnormal Fecal Immunochemical Test Results in a Safety Net System.
    Issaka RB; Bell-Brown A; Snyder C; Atkins DL; Chew L; Weiner BJ; Strate L; Inadomi JM; Ramsey SD
    JAMA Netw Open; 2021 Aug; 4(8):e2120159. PubMed ID: 34374771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timeliness of Colonoscopy After Abnormal Fecal Test Results in a Safety Net Practice.
    Oluloro A; Petrik AF; Turner A; Kapka T; Rivelli J; Carney PA; Saha S; Coronado GD
    J Community Health; 2016 Aug; 41(4):864-70. PubMed ID: 26874943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standardized Workflows Improve Colonoscopy Follow-Up After Abnormal Fecal Immunochemical Tests in a Safety-Net System.
    Issaka RB; Rachocki C; Huynh MP; Chen E; Somsouk M
    Dig Dis Sci; 2021 Mar; 66(3):768-774. PubMed ID: 32236885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Need for an Integrated Patient Navigation Pathway to Improve Access to Colonoscopy After Positive Fecal Immunochemical Testing: A Safety-Net Hospital Experience.
    Thamarasseril S; Bhuket T; Chan C; Liu B; Wong RJ
    J Community Health; 2017 Jun; 42(3):551-557. PubMed ID: 27796633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of patient, physician, and environmental factors to demographic and health variation in colonoscopy follow-up for abnormal colorectal cancer screening test results.
    Partin MR; Gravely AA; Burgess JF; Haggstrom DA; Lillie SE; Nelson DB; Nugent SM; Shaukat A; Sultan S; Walter LC; Burgess DJ
    Cancer; 2017 Sep; 123(18):3502-3512. PubMed ID: 28493543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients without colonoscopic follow-up after abnormal fecal immunochemical tests are often unaware of the abnormal result and report several barriers to colonoscopy.
    Cusumano VT; Corona E; Partida D; Yang L; Yu C; May FP
    BMC Gastroenterol; 2020 Apr; 20(1):115. PubMed ID: 32306919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inadequate Utilization of Diagnostic Colonoscopy Following Abnormal FIT Results in an Integrated Safety-Net System.
    Issaka RB; Singh MH; Oshima SM; Laleau VJ; Rachocki CD; Chen EH; Day LW; Sarkar U; Somsouk M
    Am J Gastroenterol; 2017 Feb; 112(2):375-382. PubMed ID: 28154400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers associated with inadequate follow-up of abnormal fecal immunochemical test results in a safety-net system: A mixed-methods analysis.
    Issaka RB; Bell-Brown A; Kao J; Snyder C; Atkins DL; Chew LD; Weiner BJ; Strate L; Inadomi JM; Ramsey SD
    Prev Med Rep; 2022 Aug; 28():101831. PubMed ID: 35637893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers to Follow-up Colonoscopies for Patients With Positive Results From Fecal Immunochemical Tests During Colorectal Cancer Screening.
    May FP; Yano EM; Provenzale D; Brunner J; Yu C; Phan J; Bharath P; Aby E; Dinh D; Ehrlich DS; Storage TR; Lin LD; Jamaluddin NN; Washington DL
    Clin Gastroenterol Hepatol; 2019 Feb; 17(3):469-476. PubMed ID: 29857147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers and Facilitators to Timely Colonoscopy Completion for Safety Net Clinic Patients.
    Schneider JL; Rivelli JS; Gruss I; Petrik AF; Nielson CM; Green BB; Coronado GD
    Am J Health Behav; 2020 Jul; 44(4):460-472. PubMed ID: 32553027
    [No Abstract]   [Full Text] [Related]  

  • 16. Patterns and predictors of repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States.
    Singal AG; Corley DA; Kamineni A; Garcia M; Zheng Y; Doria-Rose PV; Quinn VP; Jensen CD; Chubak J; Tiro J; Doubeni CA; Ghai NR; Skinner CS; Wernli K; Halm EA
    Am J Gastroenterol; 2018 May; 113(5):746-754. PubMed ID: 29487413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparities in Colorectal Cancer Screening Practices in a Midwest Urban Safety-Net Healthcare System.
    Elangovan A; Skeans J; Lalani I; Ullah F; Roy A; Kaelber DC; Cooper GS; Sandhu DS
    Dig Dis Sci; 2021 Aug; 66(8):2585-2594. PubMed ID: 32816217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient Navigation After Positive Fecal Immunochemical Test Results Increases Diagnostic Colonoscopy and Highlights Multilevel Barriers to Follow-Up.
    Cusumano VT; Myint A; Corona E; Yang L; Bocek J; Lopez AG; Huang MZ; Raja N; Dermenchyan A; Roh L; Han M; Croymans D; May FP
    Dig Dis Sci; 2021 Nov; 66(11):3760-3768. PubMed ID: 33609211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies to Improve Follow-up After Positive Fecal Immunochemical Tests in a Community-Based Setting: A Mixed-Methods Study.
    Selby K; Jensen CD; Zhao WK; Lee JK; Slam A; Schottinger JE; Bacchetti P; Levin TR; Corley DA
    Clin Transl Gastroenterol; 2019 Feb; 10(2):e00010. PubMed ID: 30829917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring the quality of colorectal cancer screening: the importance of follow-up.
    Etzioni DA; Yano EM; Rubenstein LV; Lee ML; Ko CY; Brook RH; Parkerton PH; Asch SM
    Dis Colon Rectum; 2006 Jul; 49(7):1002-10. PubMed ID: 16673056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.